Featured Research

from universities, journals, and other organizations

Combined use of polio vaccines effective in boosting immunity

Date:
August 21, 2014
Source:
American Association for the Advancement of Science
Summary:
New evidence suggests that giving the Salk inactivated poliovirus vaccine to individuals who had already been given the Sabin live-attenuated oral poliovirus vaccine may improve their immunity to the poliovirus. The results could help resolve controversy over vaccine choice as researchers work to hasten elimination of final poliovirus reservoirs in places like Syria and Iraq.

New evidence suggests that giving the Salk inactivated poliovirus vaccine (IPV) to individuals who had already been given the Sabin live-attenuated oral poliovirus vaccine (OPV) may improve their immunity to the poliovirus. The results, published in the 22 August issue of the journal Science, could help resolve controversy over vaccine choice as researchers work to hasten elimination of final poliovirus reservoirs in places like Syria and Iraq.

"This study revolutionized our understanding of IPV and how to use it in the global eradication effort to ensure children receive the best and quickest protection possible from this disease," said senior author Dr. Bruce Aylward, assistant director-general for Polio, Emergencies and Country Collaboration at the World Health Organization (WHO).

"IPV should be used to accelerate the eradication of the virus in populations that have limited access to vaccination," added Dr. Hamid Jafari, WHO's director for polio operations and research and the lead author of the report. "The study has also provided the evidence for use of IPV among travelers to limit further international spread of the virus."

Since the development of the polio vaccine in the 1950s, efforts to eradicate the poliovirus, which can cause life-long paralysis, relied mainly on OPV -- the choice of the Global Polio Eradication Initiative -- rather than IPV.

"This is because OPV has a superior ability to induce mucosal immunity, is easy to administer requiring no needles, and is substantially cheaper," said Caroline Ash, a senior editor at Science.

However, in parts of the globe where polio is proving difficult to eradicate, the choice between OPV and IPV continues to be widely debated by scientists. This is because mucosal immunity (the protection offered by the linings that separate the body's sterile interior from the outside world) diminishes rapidly after OPV treatment, meaning several doses of this vaccine are required. And providing multiple doses to eradicate wild poliovirus is challenging in remote areas or conflict zones like Afghanistan, Nigeria and Pakistan.

Furthermore, OPV's use can still lead to polio virus being shed in the stools, which creates risk of viral spreading.

In hopes of one day withdrawing OPV from treatment regimens, Jafari, Aylward and colleagues tested whether use of both vaccines would improve mucosal immunity; although administering IPV after OPV is known to close certain immunity gaps, its effect on intestinal mucosal immunity is less well-characterized.

The international research team conducted a large, community-based, randomized clinical trial in nearly 1,000 infants and children in Uttar Pradesh, a state located in northern India. All subjects were given one vaccine or the other. After four weeks, all subjects, regardless of the initial dose type, got a dose of OPV.

In children who were given IPV, viral shedding was reduced, meaning that these children were much less infectious to others -- a key in halting the spread of the virus.

Dr. Jafari and colleagues also found that a single dose of IPV, which is administered by injection, induced intestinal mucosal immunity more effectively in children than an additional OPV dose.

The results of this study could help resolve the 50-year-old controversy, dating back to the time of Jonas Salk and Albert Sabin, over vaccine choice. "The answer is now very clear," explained Dr. Roland Sutter, WHO's coordinator for research and product development, polio operations and research. "Both vaccines complement one another and should be used to interrupt the final chains of transmission to attain a polio-free world in the most rapid and effective way possible."

"The global eradication effort is at a critical crossroad," continued Dr. Jafari. "Endemic polio is increasingly geographically restricted to populations in insecure and inaccessible areas. Yet the virus in these areas persists with incredible tenacity and threatens the increasingly vulnerable populations in polio-free countries with weak or conflict-affected health systems."

This study was funded by the Rotary International Polio Plus Program through a grant approved by the Polio Research Committee of the World Health Organization.


Story Source:

The above story is based on materials provided by American Association for the Advancement of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. H. Jafari, J. M. Deshpande, R. W. Sutter, S. Bahl, H. Verma, M. Ahmad, A. Kunwar, R. Vishwakarma, A. Agarwal, S. Jain, C. Estivariz, R. Sethi, N. A. Molodecky, N. C. Grassly, M. A. Pallansch, A. Chatterjee, R. B. Aylward. Efficacy of inactivated poliovirus vaccine in India. Science, 2014; 345 (6199): 922 DOI: 10.1126/science.1255006

Cite This Page:

American Association for the Advancement of Science. "Combined use of polio vaccines effective in boosting immunity." ScienceDaily. ScienceDaily, 21 August 2014. <www.sciencedaily.com/releases/2014/08/140821141443.htm>.
American Association for the Advancement of Science. (2014, August 21). Combined use of polio vaccines effective in boosting immunity. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2014/08/140821141443.htm
American Association for the Advancement of Science. "Combined use of polio vaccines effective in boosting immunity." ScienceDaily. www.sciencedaily.com/releases/2014/08/140821141443.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins